Search Results

Grand Rounds "N eurofibromatosis Type 1 in Children" At the end of this presentation, participants should be able to: Demonstrate proficiency in distinguishing between the various forms of neurofibromatosis syndromes in children Demonstrate proficiency in recognizing the early

At the end of this presentation, participants should be able to: Understand potential complications of enteral tubes Identify next steps in evaluation when the tube or intestines don’t work Watch the session here . Passcode: x9J?Ek&R About the presenters: Carrie M. Schaefer, MD

At the conclusion of this presentation, participants should be able to: Define dysphagia and feeding problems related to esophageal inflammation Describe the epidemiology and demographics of children with EoE Outline the pathophysiology and clinical features of eosinophilic

Discuss patients diagnosed with complex fetal cardiac disease that are pending delivery. Discussion will occur with cardiology, maternal fetal medicine, neonatology, and cardiothoracic surgical teams present to create a prenatal and postnatal management plan.? Review fetal echo

At the end of this presentation, participants should be able to: 1. Understand the macronutrient breakdown of ketogenic therapies, potential mechanisms of action, and efficacy in seizure management. 2. Recognize and effectively manage common side effects of ketogenic therapy. 3

The Physicians and members of the healthcare team will appreciate new strategies in the management of critical illness. This will provide a comprehensive review of the clinical management, decision making, program and organizational processes related to the use of ECLS. This will

Presenter: Denis A. Cortese, MD, Healthcare Delivery & Policy, Foundation Professor and Director, Arizona State University Center for Healthcare Delivery and Policy Emeritus President and Professor of Medicine, Mayo Clinic 1. To be able to understand a construct of the systems